The Institute of Pharmaceutical Innovation

Staff

Jump to About Navigation

Organisational Chart

Prof. Peter York
Professor of Physical Pharmaceutics and Director of IPI Research Focus Group
  • Telephone: +44 (0) 1274 233890
  • Email: p.york@bradford.ac.uk

Peter is Professor of Physical Pharmaceutics at the University of Bradford. Research activities involve pharmaceutical material science, coupled to aspects of chemical engineering and processing, with particular focus on molecular modelling and solid-state structure, particle formation including novel processes using supercritical fluid technology, and drug delivery design. He has consulted widely throughout the world, published over 300 scientific articles, holds numerous patents, and has received several research awards. Peter was behind Bradford Particle Design Ltd, a spinout venture from the University of Bradford. The company, based on research and patents in particle formation by supercritical fluids, was acquired by Inhale Therapeutics (now Nektar Therapeutics) in 2001.
—————————————————————————
Research Interests

*Crystal engineering and particle design

*Solid state and material science of pharmaceuticals

*Supercritical fluid processing and technologies

*Knowledge engineering and artificial intelligence technologies

*Formulation and design science for biopharmaceuticals

*Health care issues for, and design of, paediatric medicines
—————————————————————————
Recent honours, awards, committee membership

*Doctor of Science degree, University of London, 2003

*Honorary PhD degree, University of Helsinki, 2007

*Harrison Memorial Medal, Royal Pharmaceutical Society of Great Britain, 2006

*Distinguished Pharmaceutical Scientist Award, Pharmaceutical Sciences World Congress, Kyoto, Japan 2004

*Conference Science Chairman, British Pharmaceutical Conference, 2001

*Member Pharmacy, Chemistry and Standards Expert Advisory Group, MHRA

*Commissioner, British Pharmaceutical Commission, MHRA

*Member Pharmacy Panel, Research Assessment Exercise, UK, 2001, 2008

*Chair, EUFEPS PAT Science Steering Group

*Pharmaceutical Particle Design Award, Japanese Powder Technology Society, Tokyo, Japan, 2003

*Fellow, Royal Society of Chemistry

*Fellow, Royal Pharmaceutical Society of Great Britain

*Fellow, American Association of Pharmaceutical Scientists

*Coordinator, Workshop on Paediatric Medicines, WHO, Cape Town, 2007

*Member, Scientific Advisory Board, National Institute of Pharmaceutical Technology and Education (NIPTE), University Consortium (Purdue University), USA
—————————————————————————
Selected Publications

Crystal engineering of active pharmaceutical ingredients to improve solubility

N. Blagden, M. de Matas, P.T.Gavan, P. York

Advanced Drug Delivery Research, in press (2007)

Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography

H.H.Y. Tong, B.Y. Shekunov, P. York, A.H.L. Chow

Journal of Pharmaceutical Sciences, 95(1), 228-233 (2006)

Supercritical Fluid Technology for Drug Product Development

Eds P. York, U.B. Kompella, B.Y. Shekunov

Marcel Dekker Inc, New York (2004)

Aerosolisation behaviour of micronised and supercritically-processed powders

B.Y.Shekunov, J.C. Feeley, A.H.L. Chow, H.H.Y. Tong, P. York

Aerosol Science, 34, 553-569 (2003)

Effect of varying optimisation parameters on optimisation by guided evolutionary simulated annealing (GESA) using a tablet film coat as an example formulation

A.P. Plumb, R.C. Rowe, P. York, C. Doherty

European Journal of Pharmaceutical Sciences, 18, 259-266 (2003)

Particle formation by mixing with supercritical antisolvent at high Reynolds numbers

B.Y. Shekunov, J. Baldyga and P. York

Chem. Eng. Sci., 56(7), 2421-2433 (2001)